Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 9/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.47 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.41 |
| ▸ | BRAF | P15056 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | GCGR | P47871 | 2/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.40 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14555704 | 0.79 | AR (0.47) | CYP11B2KIF11MMP3EGLN2 | |
| SCHEMBL19917498 | 0.79 | KIF11 (0.50) | CYP11B2CYP11B1KIF11MMP3EGLN2 | |
| SCHEMBL19579181 | 0.79 | KIF11 (0.48) | CYP11B2KIF11MMP3EGLN2 | |
| SCHEMBL21929166 | 0.78 | IDO1 (0.55) | CYP11B2CYP11B1NPY5R | |
| SCHEMBL19579104 | 0.78 | KIF11 (0.58) | CYP11B2CYP11B1KIF11MMP3EGLN2 | |
| SCHEMBL9987705 | 0.76 | CYP11B2 (0.51) | CYP11B2CYP11B1GCGRMAPK14 | |
| SCHEMBL3509636 | 0.75 | MMP3 (0.59) | CYP11B2KIF11MMP3 | |
| SCHEMBL16604324 | 0.74 | ALDH1A1 (0.50) | CYP11B2CYP11B1KIF11MMP3EGLN2 | |
| SCHEMBL4147130 | 0.74 | KIF11 (0.48) | CYP11B2KIF11MMP3EGLN2BRAF | |
| SCHEMBL16922704 | 0.73 | KIF11 (0.45) | CYP11B2CYP11B1KIF11MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| EP-3609978-B1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-03-17 | — | — | EP | disclosed |
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OGFR, OR51E2 | CYP11B2 902/4885CYP11B1 1431/4885KIF11 4417/4885 |
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | CYP11B2 163/4885CYP11B1 432/4885KIF11 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.